期刊文献+

脑钠肽在心力衰竭中的治疗价值 被引量:9

暂未订购
导出
出处 《临床荟萃》 CAS 2009年第12期1094-1096,共3页 Clinical Focus
  • 相关文献

参考文献21

  • 1Bettencourt P, Frioes F, Azevedo A, et al. Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure [J]. Int J Cardiol, 2004,93 (1) :45-48.
  • 2郭芳芳,孙海凤,陈晓锐,厉保秋,李应全.重组人脑钠肽对急性心衰犬血管紧张素Ⅱ和内皮素-1的影响[J].中国生化药物杂志,2008,29(4):253-255. 被引量:2
  • 3Miehaels AD,Klein A,Madden JA,et al. Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake [J]. Circulation, 2003, 107 ( 21 ) : 2697-2701.
  • 4陆国才,袁伯俊,姜华,佘佳红.重组人脑利钠肽安全药理学研究[J].中国新药杂志,2006,15(22):1937-1939. 被引量:1
  • 5Burger AJ. A review of the renal and neurohormonal effects of B-type natriuretic peptide[J]. Congest Heart Fail, 2005, 11 (1):30-38.
  • 6Aronson D, Burger AJ. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure [J]. Am Heart J, 2004, 148 (5) : e16.
  • 7Shapiro BP,Chen HH,Burnett JC Jr,et al. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure[J]. Mayo Clin Proc,2003,78(4) :481-486.
  • 8郭芳芳,谢青,厉保秋,马剑锋,王菊英,李应全.重组人脑利钠肽对急性心衰犬的保护作用[J].中国老年学杂志,2008,28(18):1776-1778. 被引量:6
  • 9Keating GM, Goa KL. Nesiritide: a review of its use in acute dccompensated heart failure[J]. Drugs, 2003,63 (1) : 47-70.
  • 10Elkayam U,Akhter MW,Singh H,et al. Comparison of effects on left ventrieular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with deeompenstated heart failure[J]. Am J Cardiol,2004,93(2) :237-240.

二级参考文献59

  • 1谌承志,肖琳玲,邓万俊.脑钠肽诊断心力衰竭的研究进展[J].临床荟萃,2006,21(3):212-215. 被引量:4
  • 2李世强,傅向华,刘君,谷新顺,张晶,樊欣娜,姜云发,苗青.静脉注射重组人脑利钠肽对急性心肌梗死伴心力衰竭患者的急性血流动力学效应的研究[J].中华心血管病杂志,2006,34(1):23-27. 被引量:102
  • 3谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 4Abraham WT,Lowes BD,Ferguson DA,et al.Systemic hemodynamic,neurohormonal,and renal excretory effects of a steady-state infusion of human brain natriuretic peptide in patients with decompensated chronic heart failure.J Card Fail,1998,4:37-44.
  • 5Mills RM,LeJemtel TH,Horton DP,et al.Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure:a randomized,double-blind,placebo-controlled clinical trial.Natrecor Study Group.J Am Coll Cardiol,1999,34:155-162.
  • 6Colucci WS,Elkayam E,Horton DP,et al.Intravenous nesiritide,a natriuretic peptide,in the treatment of decompensated heart failure.N Engl J Med,2000,343:246-253.
  • 7Kawakami R,Saito Y,Kishimoto I,et al.Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction.Circulation,2004,110:3306-3312.
  • 8Keating GM,Goa KL.Nesiritide:a review of its use in acute decompensated heart failure.Drugs,2003,63:47-70.
  • 9de Lemos JA,McGuire DK,Drazner MH.B-type natriuretic peptide in cardiovascular disease.Lancet,2003,362:316-322.
  • 10Strain WD.The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure.Int J Clin Pract,2004,58:1081-1087.

共引文献259

同被引文献79

引证文献9

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部